George C Eckert Ii

Array ( [id] => 6378647 [patent_doc_number] => 20100081709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'ISOLATED SNARE YKT6 GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/533105 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12876 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081709.pdf [firstpage_image] =>[orig_patent_app_number] => 12533105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464427 [patent_doc_number] => 20090324627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'ISOLATED DNA DIRECTED 50kD REGULATORY SUBUNIT (POLD2) GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/533164 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12869 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324627.pdf [firstpage_image] =>[orig_patent_app_number] => 12533164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464426 [patent_doc_number] => 20090324626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'ISOLATED SNARE YKT6 GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/533130 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12872 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324626.pdf [firstpage_image] =>[orig_patent_app_number] => 12533130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802361 [patent_doc_number] => 08440635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Oligonucleotide conjugates' [patent_app_type] => utility [patent_app_number] => 12/504931 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12876 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12504931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958493 [patent_doc_number] => 20110182880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Combination Therapies Against Cancer' [patent_app_type] => utility [patent_app_number] => 12/999395 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 10574 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182880.pdf [firstpage_image] =>[orig_patent_app_number] => 12999395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014939 [patent_doc_number] => 20110223204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'TREATMENT OF PAIN WITH GAP JUNCTION MODULATION COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/996359 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24863 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223204.pdf [firstpage_image] =>[orig_patent_app_number] => 12996359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7966235 [patent_doc_number] => 07939507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Potent LNA oligonucleotides for the inhibition of HIF-1a expression' [patent_app_type] => utility [patent_app_number] => 12/477261 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 42 [patent_no_of_words] => 22927 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939507.pdf [firstpage_image] =>[orig_patent_app_number] => 12477261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8095815 [patent_doc_number] => 20120083519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Methods For Diagnosing And Treating A Renal Disease In An Individual' [patent_app_type] => utility [patent_app_number] => 13/375854 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9597 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083519.pdf [firstpage_image] =>[orig_patent_app_number] => 13375854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6437735 [patent_doc_number] => 20100144026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'siRNA-mediated gene silencing with viral vectors' [patent_app_type] => utility [patent_app_number] => 12/455018 [patent_app_country] => US [patent_app_date] => 2009-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21179 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144026.pdf [firstpage_image] =>[orig_patent_app_number] => 12455018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174387 [patent_doc_number] => 20110177097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'METHODS FOR MODULATING EXPRESSION OF CREB' [patent_app_type] => utility [patent_app_number] => 12/993435 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 53647 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177097.pdf [firstpage_image] =>[orig_patent_app_number] => 12993435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11177957 [patent_doc_number] => 09409941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => '5′ triphosphate oligonucleotide with blunt end and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/993420 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 33 [patent_no_of_words] => 35973 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11177957 [patent_doc_number] => 09409941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => '5′ triphosphate oligonucleotide with blunt end and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/993420 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 33 [patent_no_of_words] => 35973 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11177957 [patent_doc_number] => 09409941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => '5′ triphosphate oligonucleotide with blunt end and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/993420 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 33 [patent_no_of_words] => 35973 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11177957 [patent_doc_number] => 09409941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => '5′ triphosphate oligonucleotide with blunt end and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/993420 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 33 [patent_no_of_words] => 35973 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003443 [patent_doc_number] => 20110118341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'LONG TERM DISEASE MODIFICATION USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/992590 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 28449 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118341.pdf [firstpage_image] =>[orig_patent_app_number] => 12992590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199590 [patent_doc_number] => 20120122953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'METHODS FOR ENHANCING UTROPHIN PRODUCTION VIA INHIBITION OF MICRORNA' [patent_app_type] => utility [patent_app_number] => 12/989758 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9109 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122953.pdf [firstpage_image] =>[orig_patent_app_number] => 12989758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118623 [patent_doc_number] => 20110076296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'TLR3 Agonist Compositions' [patent_app_type] => utility [patent_app_number] => 12/988815 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 62235 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076296.pdf [firstpage_image] =>[orig_patent_app_number] => 12988815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539872 [patent_doc_number] => 20090221677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Methods for Reducing Body Fat and Increasing Lean Body Mass by Reducing Stearoyl-COA Desaturase 1 Activity' [patent_app_type] => utility [patent_app_number] => 12/405576 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14858 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221677.pdf [firstpage_image] =>[orig_patent_app_number] => 12405576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163488 [patent_doc_number] => 20110160285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'IDENTIFICATION OF MIRNA PROFILES THAT ARE DIAGNOSTIC OF HYPERTROPHIC CARDIOMYOPATHY' [patent_app_type] => utility [patent_app_number] => 12/921827 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12952 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160285.pdf [firstpage_image] =>[orig_patent_app_number] => 12921827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434942 [patent_doc_number] => 20090169528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'KERATINOCYTES EXPRESSING EXOGENOUS ANGIOGENIC GROWTH FACTORS' [patent_app_type] => utility [patent_app_number] => 12/392221 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20256 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169528.pdf [firstpage_image] =>[orig_patent_app_number] => 12392221 [rel_patent_id] =>[rel_patent_doc_number] =>)